Product launch

Product launch Agency Consulting firm Experts Specialists Consultancy

Successfully launch and market your new product

For more than 30 years, our specialized team has been supporting companies in their product launches projects from the definition of the marketing strategy to the first sales.

    Tell us about your uncharted territory

    You have a project and want to discuss it with our explorers, write us!

    One of our explorers will contact you shortly.

    They trust us


    Key success factors for a product launch

    Investing in a solid product launch strategy is crucial for companies aiming for sustained growth and a position as market leader . A successful product launch guarantees a high and rapid return on investment. To maximize the success of a new product launch, there are 3 key success factors to consider:

    How we support you in your product launch strategies

    To help our clients successfully prepare their product launch initiatives, our teams are involved from upstream marketing analysis and strategy (regulatory analysis, competitive environment mapping, choice of market positioning and market segments, estimation of market potential, etc.), to marketing strategy (choice of business model, distribution channels, price positioning, identification of potential partners, etc.), through to the first contracts and first sales (assistance with prospecting, business development, etc.).

    Examples of recent product launch strategies carried out for our clients

    • Marketing strategy: definition of a product launch plan for the deployment of a new combined health offer

      We supported a pharmaceutical company in the launch of a combined offer, which consisted in adding a communication platform between the patient and healthcare professionals to a medical device.

      By analyzing the receptiveness of the medical community to this new combined offer, Alcimed enabled its client to establish the most appropriate marketing strategy for the launch of its product.

      This was then concretized from an operational point of view by accompanying the sales teams in the construction of their communication supports (presentation materials, sales pitch,…) in order to facilitate the integration of the messages and their diffusion to the different communities of healthcare professionals.

    • Marketing plan : preparation of a marketing campaign for the launch of alcohol-free beers

      We assisted a major company in the agri-food industry in developing a marketing campaign plan to promote the health benefits of alcohol-free beer in preparation for the new products launch.

      By developing a set of marketing arguments based on an in-depth scientific analysis, and identifying market events on the theme of nutrition and potential influencers, Alcimed enabled its client to prepare its product launches plan in more than ten markets worldwide.

    • Preparing a product launch plan: roadmap for an orphan drug launch project in Europe

      Alcimed assisted an American biopharmaceutical client in defining the launch strategy of its orphan drug in Europe, and then in structuring a concrete and operational plan, both at the level of the European region and at the level of each targeted country.

      The launch plan is a roadmap for each of the company’s key functions (medical, marketing, production, regulatory, sales) and covers the period from pre-launch (before obtaining the MA – Marketing Authorization) to the first sales.

      Today, our team is still involved in regularly updating the first plan defined with our client, according to internal or external developments around this orphan drug in several European countries.

    • Market access strategy for a product launch: preparation for the launch of a new CAR-T therapy

      We assisted a leading company in the field of CAR-T therapies in preparing the launch of its new treatment and in defining its market access strategy in the US, Canada and Europe. CAR-Ts are highly personalized technologies that require a high level of specialization to be delivered to patients, and therefore not all healthcare facilities are ready to administer them. In this context, and in order to define the market access strategy for its new treatment, we helped our client to:

      1. Understand and identify which centers would have the capacity to deliver CAR-T.
      2. Analyze the bottlenecks to approval this new product in the relevant markets.
      3. Consequently, define the actions to be implemented to ensure access to their new CAR-T therapy.

      Following an investigation of over 200 healthcare centers in the US, Canada and Europe, our analysis enabled us to recommend to our client the key next steps to take to ensure their new product launch, including developing the skills of each center and facilitating rapid market access for their new treatment.

    • Deciphering the current hematological malignancy care pathway to ensure the success of a pharmaceutical company's product launch

      Alcimed assisted a pharmaceutical company in the launch of its new product for the treatment of a hemopathy in France.

      To define the right strategic and communication axes for the product launch, we investigated the current care pathway, particularly with regard to the use of blood transfusion, the reference treatment for the pathology, in order to identify the main pain points and better characterize the current burden of the disease, not only for patients, but also for hospitals.

      Following an investigation carried out with hematologists, nurses, biologists, patient associations and KOLs, we were able to provide our client with a detailed understanding of the current ecosystem for managing this pathology and the unmet needs of all stakeholders, beyond the direct prescribers. This contributed to the clear identification of the new product’s expectations and strengths. Alcimed was thus able to define the positioning and messages that would guarantee a successful launch.

    • Estimation of the potential number of patients who could benefit from a new endocrinology treatment in France

      Alcimed helped a pharmaceutical company to assess the level of investment required to launch a new endocrinology product. The aim was to gain a better understanding of the precise endocrine disease in France, and to estimate the potential number of patients this pathology represents in this market.

      To achieve this, we implemented a three-stage methodology to decipher management practices and patient pathways, identify potential patient pools, and guide the decision around the business opportunity of treatment.

      In the end, the project delivered a detailed analysis, including assumptions for quantifying the epidemiology of the pathology in France, an assessment of the business opportunity for its client and the implications in terms of the GO/NO GO decision to invest in this indication.

    You have a project?

      Tell us about your uncharted territory

      You have a project and want to discuss it with our explorers, write us!

      One of our explorers will contact you shortly.